Quantcast

Latest JDRF Stories

2014-07-25 23:04:27

New report from the Juvenile Diabetes Cure Alliance analyzes the JDRF’s revenue and spending during fiscal year 2013 to find research spending down by $50 million since 2008 peak, while all other expense categories increased. New York, New York (PRWEB) July 25, 2014 A report released by the Juvenile Diabetes Cure Alliance reviews JDRF’s revenue and spending during fiscal year 2013 (July 1, 2012- June 30, 2013). Outside of the US government’s National Institutes of Health (NIH), the...

2014-07-21 12:24:39

Passionate volunteer will now lead organization toward life-changing treatments on path to ultimate cure for type one diabetes (T1D) NEW YORK, July 21, 2014 /PRNewswire/ -- JDRF's International Board of Directors (IBOD) announced today the appointment of Derek Rapp, currently Vice Chair of the JDRF International Board of Directors, as its new President and CEO. http://photos.prnewswire.com/prnvar/20140721/128866 Rapp replaces Jeffrey Brewer who recently left his role as JDRF...

2014-07-17 16:25:37

NEW YORK, July 17, 2014 /PRNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today ViaCyte, Inc., a leading regenerative medicine company, has filed an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of the VC-01(TM) product candidate, a stem...

2014-07-17 08:30:21

SAN DIEGO, July 17, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, today announced that it has filed an Investigational New Drug application (IND) with the United States Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of ViaCyte's VC-01(TM) product candidate, a stem...

2014-07-09 08:27:32

Trial to Evaluate Efficacy and Safety of LX4211 in Younger Population THE WOODLANDS, Texas, July 9, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D) research, will provide funding to support a Phase 2, randomized, double-masked, placebo-controlled clinical trial to evaluate the efficacy and safety of LX4211 in a younger population with T1D. Up to 76 individuals with T1D,...

2014-07-08 23:12:38

Fit4D’s Pathways optimizes the mix between intelligent technology and human touch points to personalize the experience for patients while using claim and pharmacy data to measure health improvements. New York, New York (PRWEB) July 08, 2014 Fit4D© (http://www.fit4d.com) announced today that it is partnering with Healthfirst to deliver an evidence-based diabetes program to Healthfirst’s Spanish speaking members with poorly managed diabetes in New York City. This program will...

2014-07-08 16:20:35

- Carson Magee, an 11-year-old fifth grader from Coeur d'Alene, Idaho who was diagnosed with type 1 diabetes (T1D) four years ago at age 7, has won the "Our Everyday Heroes" Race Car Design Contest for JDRF, hosted by Ford Customer Service Division (FCSD) and its brands, Motorcraft and Quick Lane Tire and Auto Centers. DEARBORN, Mich., July 8, 2014 /PRNewswire/ -- Carson Magee, an 11-year-old fifth grader from Coeur d'Alene, Idaho who was diagnosed with type 1 diabetes (T1D) four...

2014-06-18 16:27:04

The Diabetes Advocacy Alliance(TM) Urges Congress to Pass the National Diabetes Clinical Care Commission Act This Congressional Session WASHINGTON, June 18, 2014 /PRNewswire-USNewswire/ -- In light of startling new data from the Center for Disease Control and Prevention's (CDC) National Diabetes Statistics Report, 2014, which show the relentless rise of diabetes and prediabetes in America, the Diabetes Advocacy Alliance(TM) (DAA) urges Congress to pass the National Diabetes Clinical...

2014-06-16 18:01:02

Tonic Life Communications USA Presented at the American Diabetes Association Scientific Sessions Animas Corporation today shared encouraging results from its predictive hypoglycemia-minimizing algorithm in development. Data from a clinical feasibility study demonstrated that the algorithm was capable of helping maintain glucose above hypoglycemic levels an average of 99.1 percent of the time for the 12 participants investigated, all of whom were adults with type 1 diabetes. The study...

2014-06-11 23:07:57

Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has been recruited to lead a newly established Institute of Cellular Therapeutics based at Allegheny General Hospital (AGH). Pittsburgh, PA (PRWEB) June 11, 2014 Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related